← Back to Search

Behavioural Intervention

Telehealth-Based Walking Program for Peripheral Arterial Disease (TREK-PAD Trial)

N/A
Waitlist Available
Led By Elizabeth A Jackson, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of lower extremity PAD due to atherosclerosis
Claudication with walking defined as stage 1-3 on the Rutherford Scale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 36 weeks
Awards & highlights

TREK-PAD Trial Summary

This trial will test two methods of delivering a home-based walking program to adults with peripheral arterial disease to improve their ability to walk for longer periods and quality of life.

Who is the study for?
This trial is for men and women with lower extremity peripheral arterial disease (PAD) who experience claudication, can walk at least one block, have internet access, and do less than 150 minutes of physical activity per week. Excluded are those in nursing homes, with unstable heart conditions or recent cardiovascular events, planned surgeries, substance abuse issues, severe psychiatric disorders or comorbidities that severely limit walking.Check my eligibility
What is being tested?
The study tests two home-based walking program delivery methods for PAD patients: web-based and telehealth. Participants will be randomly assigned to one method or usual care for 12 weeks; some may then try a combination of both methods for another 12 weeks. The total study duration is 36 weeks including follow-ups with treadmill walks and quality of life questionnaires.See study design
What are the potential side effects?
Since the intervention involves a walking program delivered either via the internet or telehealth without medications involved, side effects are minimal but could include typical exercise-related issues such as muscle soreness or fatigue.

TREK-PAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with PAD in my legs due to clogged arteries.
Select...
I experience leg pain when walking but can walk without assistance.
Select...
I can walk at least one city block without help.
Select...
I understand and can agree to the study's procedures and risks.

TREK-PAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in PAD-specific health-related quality of life
Change in claudication free walking distance
Change in general health-quality of life
+1 more

TREK-PAD Trial Design

2Treatment groups
Experimental Treatment
Group I: Telehealth Counseling Walking ProgramExperimental Treatment1 Intervention
Telehealth sessions allow participants review step-count goals, progress over time and access to walking tips with the study coordinator
Group II: Internet-based Walking ProgramExperimental Treatment1 Intervention
Internet pages allow participants to see step-count goals, progress over time and access to walking tips

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,378 Total Patients Enrolled
12 Trials studying Peripheral Arterial Disease
787 Patients Enrolled for Peripheral Arterial Disease
Elizabeth A Jackson, MDPrincipal InvestigatorBirmingham VA Medical Center, Birmingham, AL

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this clinical trial still ongoing?

"As documented on clinicaltrials.gov, this trial is not currently recruiting subjects. Though initially posted in January of 2024 and last modified in September of 2023, no further entries are being accepted at the present time. However, there are 207 different medical studies that remain open for enrollment right now."

Answered by AI
~150 spots leftby Oct 2027